Related references
Note: Only part of the references are listed.The effects of beta-2 adrenergic agonist and antagonist on human bone metabolism: A randomized controlled trial
A. G. Veldhuis-Vlug et al.
BONE (2015)
β-adrenergic receptor antagonists and fracture risk: a meta-analysis of selectivity, gender, and site-specific effects
K. A. Toulis et al.
OSTEOPOROSIS INTERNATIONAL (2014)
The Skeleton and the Sympathetic Nervous System: It's about Time!
Katherine J. Motyl et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Relationship of Sympathetic Activity to Bone Microstructure, Turnover, and Plasma Osteopontin Levels in Women
Joshua N. Farr et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Bone Resorption Is Increased in Pheochromocytoma Patients and Normalizes following Adrenalectomy
A. G. Veldhuis-Vlug et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Continuous Treatment with a Low-Dose beta-Agonist Reduces Bone Mass by Increasing Bone Resorption Without Suppressing Bone Formation
Hisataka Kondo et al.
CALCIFIED TISSUE INTERNATIONAL (2011)
Genetic determination of the cellular basis of the sympathetic regulation of bone mass accrual
Daisuke Kajimura et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Effect of Inhaled Glucocorticoids and β2 Agonists on Vertebral Fracture Risk in COPD Patients: The EOLO Study
S. Gonnelli et al.
CALCIFIED TISSUE INTERNATIONAL (2010)
Fracture risk in patients with chronic lung diseases treated with bronchodilator drugs and inhaled and oral corticosteroids
Peter Vestergaard et al.
CHEST (2007)
Use of beta-2 agonists and risk of hip/femur fracture: a population-based case-control study
Frank de Vries et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
Protective effect of β blockers in postmenopausal women:: Influence on fractures, bone density, micro and macroarchitecture
N. Bonnet et al.
BONE (2007)
Summary of the International Society for Clinical Densitometry 2005 Position Development Conference
Neil Binkley et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
Use of β-blockers and the risk of hip/femur fracture in the United Kingdom and the Netherlands
F. de Vries et al.
CALCIFIED TISSUE INTERNATIONAL (2007)
Dose effects of propranolol on cancellous and cortical bone in ovariectomized adult rats
N. Bonnet et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Transforming growth factor-β1 to the bone
K Janssens et al.
ENDOCRINE REVIEWS (2005)
Effects of a β-blocker on bone turnover in normal postmenopausal women:: A randomized controlled trial
IR Reid et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Leptin regulation of bone resorption by the sympathetic nervous system and CART
F Elefteriou et al.
NATURE (2005)
Potential role of pancreatic and enteric hormones in regulating bone turnover
JA Clowes et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2005)
Leptin deficiency - Lessons in regional differences in the regulation of bone mass
IR Reid
BONE (2004)
Use of β-blockers and risk of fractures
RG Schlienger et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Genetic regulation of osteoclast development and function
SL Teitelbaum et al.
NATURE REVIEWS GENETICS (2003)
Leptin regulates bone formation via the sympathetic nervous system
S Takeda et al.
CELL (2002)
Discoveries, drugs and skeletal disorders
D Goltzman
NATURE REVIEWS DRUG DISCOVERY (2002)
Effects of biomechanical stress on bones in animals
DB Burr et al.
BONE (2002)
Share Paper
